Covered recipient · General Payments record
JOHN STURGIS
General Payments · PY2024
$279.90
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $279.90 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $112.19 | 1 |
| Alexion Pharmaceuticals, Inc. | $73.50 | 3 |
| Acerta Pharma LLC | $35.56 | 2 |
| Grifols USA, LLC | $24.51 | 1 |
| Lilly USA, LLC | $19.63 | 1 |
| GENZYME CORPORATION | $14.51 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $279.90 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $25.74 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508784 | CMS |
| Alexion Pharmaceuticals, Inc. | $25.19 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110510968 | CMS |
| Alexion Pharmaceuticals, Inc. | $22.57 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110511926 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.85 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110510098 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.71 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508020 | CMS |
| GENZYME CORPORATION | $14.51 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139793835 | CMS |
| Grifols USA, LLC | $24.51 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124745176 | CMS |
| Lilly USA, LLC | $19.63 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135058432 | CMS |
| UCB, Inc. | $112.19 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143094639 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.